Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 7, 2008, Pages 2686-2690

  Betriu, Carmen ^a   Culebras, Esther ^a   Gómez, María ^a   López, Fátima ^a   Rodríguez Avial, Iciar ^a   Picazo, Juan J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFOXITIN; CHLORAMPHENICOL; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTEROIDES FRAGILIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SPAIN;

ANTI-BACTERIAL AGENTS; BACTEROIDES; BACTEROIDES FRAGILIS; BACTEROIDES INFECTIONS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; SPAIN; SPECIES SPECIFICITY; TIME FACTORS;

EID: 46249120195     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00081-08     Document Type: Article

References (19)

1. Aldridge, K. E., D. Ashcraft, K. Cambre, C. L. Pierson, S. G. Jenkins, and J. E. Rosenblatt. 2001. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob. Agents Chemother. 45:1238-1243.
2. Betriu, C., C. Cabronero, M. Gómez, and J. J. Picazo. 1992. Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989. Eur. J. Clin. Microbiol. Infect. Dis. 11:352-356.
3. Betriu, C., I. Rodríguez-Avial, M. Gómez, E. Culebras, and J. J. Picazo. 2005. Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002). Diagn. Microbiol. Infect. Dis. 53:221-223.
4. Clinical Laboratory Standards Institute. 2007. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard. CLSI document M11-A7. CLSI, Wayne, Pa.
5. Golan, Y., L. A. McDermott, N. V. Jacobus, E. J. Goldstein, S. Finegold, L. J. Harrell, D. W. Hecht, S. G. Jenkins, C. Pierson, R. Venezia, J. Rihs, P. Iannini, S. L. Gorbach, and D. R. Snydman. 2003. Emergence of fluoroquinolone resistance among Bacteroides species. J. Antimicrob. Chemother. 52:208-213.
6. Horn, R., and H. G. Robson. 2001. Susceptibility of the Bacteroides fragilis group to newer quinolones and other standard anti-anaerobic agents. J. Antimicrob. Chemother. 48:127-130.
7. Jacobus, N. V., L. A. McDermott, R. Ruthazer, and D. R. Snydman. 2004. In vitro activities of tigecycline against the Bacteroides fragilis group. Antimicrob. Agents Chemother. 48:1034-1036.
8. Katsandri, A., A. Avlamis, A. Pantazatou, G. L. Petrikkos, N. J. Legakis, and J. Papaparaskevas. 2006. In vitro activities of tigecycline against recently isolated Gram-negative anaerobic bacteria in Greece, including metronidazole-resistant strains. Diagn. Microbiol. Infect. Dis. 55:231-236.
9. Lassmann, B., D. R. Gustafson, C. M. Wood, and J. E. Rosenblatt. 2007. Reemergence of anaerobic bacteremia. Clin. Infect. Dis. 44:895-900.
10. National Committee for Clinical Laboratory Standards. 2004. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 6th ed. Approved standard. NCCLS publication M11-A6. NCCLS, Wayne, Pa.
11. Nguyen, M. H., V. L. Yu, A. J. Morris, L. McDermott, M. W. Wagener, L. Harrell, and D. R. Snydman. 2000. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin. Infect. Dis. 30:870-876.
12. Oteo-Iglesias, J., J. I. Alós, and J. L. Gómez- Garcés. 2002. Increase in resistance to new fluoroquinolones from 1998 to 2001 in the Bacteroides fragilis group. J. Antimicrob. Chemother. 50:1055-1057.
13. Papaparaskevas, J., A. Pantazatou, A. Katsandri, N. J. Legakis, and A. Avlamis. 2005. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece. Clin. Microbiol. Infect. 11:820-824.
14. Rotimi, V. O., M. Khoursheed, J. S. Brazier, W. Y. Jamal, and F. B. Khodakhast. 1999. Bacteroides species highly resistant to metronidazole: an emerging clinical problem? Clin. Microbiol. Infect 5:166-169.
15. Salonen, J. H., E. Eerola, and O. Meurman. 1998. Clinical significance and outcome of anaerobic bacteremia. Clin. Infect. Dis. 26:1413-1417.
16. Snydman, D. R., N. V. Jacobus, L. A. McDermott, R. Ruthazer, Y. Golan, E. J. Goldstein, S. M. Finegold, L. J. Harrell, D. W. Hecht, S. G. Jenkins, C. Pierson, R. Venezia, V. Yu, J. Rihs, and S. L. Gorbach. 2007. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob. Agents Chemother. 51:1649-1655.
17. Snydman, D. R., N. V. Jacobus, L. A. McDermott, R. Ruthazer, E. J. Goldstein, S. M. Finegold, L. J. Harrell, D. W. Hecht, S. G. Jenkins, C. Pierson, R. Venezia, J. Rihs, and S. L. Gorbach. 2002. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends for 1997-2000. Clin. Infect. Dis. 35:S126-S134.
18. Teng, L. J., P. R. Hsueh, J. C. Tsai, S. J. Liaw, S. W. Ho, and K. T. Luh. 2002. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan. Antimicrob. Agents Chemother. 46:2908-2913.
19. Wybo, I., D. Pierard, I. Verschraegen, M. Reynders, K. Vandoorslaer, G. Claeys, M. Delmee, Y. Glupczynski, B. Gordts, M. Ieven, P. Melin, M. Struelens, J. Verhaegen, and S. Lauwers. 2007. Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J. Antimicrob. Chemother. 59:132-139.